Palantir reported its fastest revenue growth ever at nearly 93%, beating earnings estimates for the ninth consecutive quarter and raising its full-year revenue guidance to over $8.15 billion. The company’s strong performance, including a 62% adjusted operating margin and expanding AI partnerships, has led 21 analysts to rate the stock as a buy, with a price target around $202. Despite a high valuation and some risks like government contract terminations, Palantir’s growth outpaces peers like Snowflake and MongoDB, suggesting potential for continued long-term gains. Investors should watch U.S. commercial growth and deal activity to gauge future momentum.
Palantir Technologies shares trade at USD 191.76 on Pluang as of Oct 02, 2026 21:11 WIB, close to their 52-week high of USD 207.18. The stock shows a modest 1-day gain of 0.91%, with a market cap of $456.68 billion. Despite strong analyst buy ratings, Pluang order activity leans toward selling at 68%, reflecting mixed investor sentiment.
Palantir reported its ninth consecutive earnings beat with second-quarter revenue up 92.8%, driven by 149% growth in U.S. commercial revenue. The company raised its full-year revenue guidance to $8.15 billion, reflecting 82% growth. Despite a premium...
IBM shares rose 5% after the company introduced a self-hosted version of its Bob AI coding agent, allowing enterprises to run the software on their own secure infrastructure. This move targets regulated and sovereignty-constrained organizations that ...
Palantir has demonstrated exceptional growth with 115% year-over-year US revenue increase and strong free cash flow margins of 63%, nearing $5 billion annualized free cash flow. The company closed 220 deals worth over $1 million each and projects Q3 ...
Palantir's Ontology and AIP software platforms are increasingly embedded in customer operations, creating high switching costs and facilitating easier deployment of additional applications. This strong integration supports significant revenue growth ...
Palantir Technologies maintains a Buy rating with a price target of $287.20, implying 53% upside driven by strong growth and margin expansion. Q3 expectations are high, with revenue and EPS consensus above guidance, but investors want a full-year gui...
